Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1945 1
1957 1
1960 2
1964 1
1966 2
1967 2
1968 1
1972 1
1973 2
1976 1
1977 1
1978 1
1981 1
1982 1
1983 2
1984 3
1985 1
1988 4
1989 2
1990 3
1991 6
1992 7
1993 1
1994 1
1996 3
1997 3
1998 2
1999 1
2001 2
2002 5
2003 2
2004 10
2005 13
2006 12
2007 11
2008 6
2009 7
2010 6
2011 7
2012 1
2013 4
2014 8
2015 2
2016 2
2017 2
2018 8
2019 10
2020 9
2021 10
2022 8
2023 8
2024 9
2025 13
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy.
Li K, Tandurella JA, Gai J, Zhu Q, Lim SJ, Thomas DL 2nd, Xia T, Mo G, Mitchell JT, Montagne J, Lyman M, Danilova LV, Zimmerman JW, Kinny-Köster B, Zhang T, Chen L, Blair AB, Heumann T, Parkinson R, Durham JN, Narang AK, Anders RA, Wolfgang CL, Laheru DA, He J, Osipov A, Thompson ED, Wang H, Fertig EJ, Jaffee EM, Zheng L. Li K, et al. Among authors: parkinson r. Cancer Cell. 2022 Nov 14;40(11):1374-1391.e7. doi: 10.1016/j.ccell.2022.10.001. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306792 Free PMC article.
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics.
Roberts MJ, Papa N, Veerman H, de Bie K, Morton A, Franklin A, Raveenthiran S, Yaxley WJ, Donswijk ML, van der Poel HG, Samaratunga H, Wong D, Brown N, Parkinson R, Gianduzzo T, Kua B, Coughlin GD, Oprea-Lager DE, Emmett L, van Leeuwen PJ, Yaxley JW, Vis AN. Roberts MJ, et al. Among authors: parkinson r. BJU Int. 2024 Dec;134 Suppl 2(Suppl 2):47-55. doi: 10.1111/bju.16482. Epub 2024 Sep 11. BJU Int. 2024. PMID: 39262180 Free PMC article.
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells.
Wang J, Gai J, Zhang T, Niu N, Qi H, Thomas DL 2nd, Li K, Xia T, Rodriguez C, Parkinson R, Durham J, McPhaul T, Narang AK, Anders RA, Osipov A, Wang H, He J, Laheru DA, Herman JM, Lee V, Jaffee EM, Thompson ED, Zhu Q, Zheng L. Wang J, et al. Among authors: parkinson r. Sci Adv. 2024 Feb 9;10(6):eadk1827. doi: 10.1126/sciadv.adk1827. Epub 2024 Feb 7. Sci Adv. 2024. PMID: 38324679 Free PMC article.
Usage of unicompartmental knee arthroplasty.
Murray DW, Parkinson RW. Murray DW, et al. Among authors: parkinson rw. Bone Joint J. 2018 Apr 1;100-B(4):432-435. doi: 10.1302/0301-620X.100B4.BJJ-2017-0716.R1. Bone Joint J. 2018. PMID: 29629577 Review.
Short small-bowel syndrome.
Parkinson RS, Walker-Smith JA. Parkinson RS, et al. Med J Aust. 1973 Aug 4;2(5):205-10. doi: 10.5694/j.1326-5377.1973.tb128784.x. Med J Aust. 1973. PMID: 4200660 No abstract available.
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma.
Heumann T, Judkins C, Li K, Lim SJ, Hoare J, Parkinson R, Cao H, Zhang T, Gai J, Celiker B, Zhu Q, McPhaul T, Durham J, Purtell K, Klein R, Laheru D, De Jesus-Acosta A, Le DT, Narang A, Anders R, Burkhart R, Burns W, Soares K, Wolfgang C, Thompson E, Jaffee E, Wang H, He J, Zheng L. Heumann T, et al. Among authors: parkinson r. Nat Commun. 2023 Jun 20;14(1):3650. doi: 10.1038/s41467-023-39196-9. Nat Commun. 2023. PMID: 37339979 Free PMC article. Clinical Trial.
A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma.
Agarwal P, Guo M, Munjal K, Qi H, Parkinson R, Ferguson A, Mitchell C, Harrison J, Anders RA, Thompson ED, Wang H, De Jesus A, Zheng L, He J, Burkhart R, Narang A, George B, Jaffee EM, Yarchoan M, Laheru D, Osipov A. Agarwal P, et al. Among authors: parkinson r. Clin Cancer Res. 2025 Aug 1;31(15):3205-3214. doi: 10.1158/1078-0432.CCR-24-3403. Clin Cancer Res. 2025. PMID: 40407726 Clinical Trial.
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal Adenocarcinoma.
Hill CS, Parkinson R, Jaffee EM, Sugar E, Zheng L, Onners B, Weiss MJ, Wolfgang CL, Cameron JL, Pawlik TM, Rosati L, Le DT, Hacker-Prietz A, Lutz ER, Schulick R, Narang AK, Laheru DA, Herman JM. Hill CS, et al. Among authors: parkinson r. Int J Radiat Oncol Biol Phys. 2025 Mar 15;121(4):930-941. doi: 10.1016/j.ijrobp.2024.10.039. Epub 2024 Nov 14. Int J Radiat Oncol Biol Phys. 2025. PMID: 39547453 Clinical Trial.
Bladder leiomyoma masquerading as a ureterocele.
Grice P, O'Dowd S, Parkinson R, Bazo A. Grice P, et al. Among authors: parkinson r. BMJ Case Rep. 2021 Jun 15;14(6):e242866. doi: 10.1136/bcr-2021-242866. BMJ Case Rep. 2021. PMID: 34130981 Free PMC article.
212 results